16-58521227-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_016284.5(CNOT1):c.7008G>A(p.Lys2336=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000237 in 1,614,014 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00025 ( 0 hom. )
Consequence
CNOT1
NM_016284.5 synonymous
NM_016284.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.01
Genes affected
CNOT1 (HGNC:7877): (CCR4-NOT transcription complex subunit 1) Enables armadillo repeat domain binding activity; molecular adaptor activity; and nuclear receptor binding activity. Contributes to poly(A)-specific ribonuclease activity. Involved in several processes, including negative regulation of signal transduction; positive regulation of cytoplasmic mRNA processing body assembly; and regulation of gene expression. Located in P-body and cytosol. Part of CCR4-NOT complex. Implicated in holoprosencephaly. [provided by Alliance of Genome Resources, Apr 2022]
SETD6 (HGNC:26116): (SET domain containing 6, protein lysine methyltransferase) This gene encodes a methyltransferase that adds a methyl group to the histone H2AZ, which is involved in nuclear receptor-dependent transcription. The protein also interacts with several endogenous proteins which are involved in nuclear hormone receptor signaling. A related pseudogene is located on chromosome 2. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.37).
BP6
Variant 16-58521227-C-T is Benign according to our data. Variant chr16-58521227-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 2065312.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.01 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000112 (17/152182) while in subpopulation NFE AF= 0.00022 (15/68030). AF 95% confidence interval is 0.000135. There are 0 homozygotes in gnomad4. There are 7 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 17 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CNOT1 | NM_016284.5 | c.7008G>A | p.Lys2336= | synonymous_variant | 48/49 | ENST00000317147.10 | NP_057368.3 | |
SETD6 | NM_001160305.4 | c.*2198C>T | 3_prime_UTR_variant | 8/8 | ENST00000219315.9 | NP_001153777.1 | ||
CNOT1 | NM_001265612.2 | c.6993G>A | p.Lys2331= | synonymous_variant | 48/49 | NP_001252541.1 | ||
CNOT1 | NR_049763.2 | n.7449G>A | non_coding_transcript_exon_variant | 49/50 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CNOT1 | ENST00000317147.10 | c.7008G>A | p.Lys2336= | synonymous_variant | 48/49 | 1 | NM_016284.5 | ENSP00000320949 | P3 | |
SETD6 | ENST00000219315.9 | c.*2198C>T | 3_prime_UTR_variant | 8/8 | 1 | NM_001160305.4 | ENSP00000219315 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152182Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
17
AN:
152182
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000155 AC: 39AN: 251334Hom.: 0 AF XY: 0.000184 AC XY: 25AN XY: 135868
GnomAD3 exomes
AF:
AC:
39
AN:
251334
Hom.:
AF XY:
AC XY:
25
AN XY:
135868
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000250 AC: 366AN: 1461832Hom.: 0 Cov.: 31 AF XY: 0.000245 AC XY: 178AN XY: 727216
GnomAD4 exome
AF:
AC:
366
AN:
1461832
Hom.:
Cov.:
31
AF XY:
AC XY:
178
AN XY:
727216
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000112 AC: 17AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74338
GnomAD4 genome
AF:
AC:
17
AN:
152182
Hom.:
Cov.:
32
AF XY:
AC XY:
7
AN XY:
74338
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | CNOT1: BP4 - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 13, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at